Among their 617 patients, 490 (69.7%) did not receive first-line mCSPC treatment intensification, Neeraj Agarwal, MD, of Huntsman Cancer Institute, University of Utah, Salt Lake City, and ...

This is the first step towards fully enrolling the study later this year, and finding new treatment pathways for patients with resistant hypertension.” An estimated 1.28 billion adults aged 30 ...

is the first anti-PD-1 mAb for the first-line treatment of SCLC and has been approved in China, the EU and several SEA countries. Focusing on lung and gastrointestinal cancer, the synergy of ...

This is the first step towards fully enrolling the study later this year, and finding new treatment pathways for patients with resistant hypertension.” An estimated 1.28 billion adults aged 30-79 ...

ONAPGO is the first and only subcutaneous apomorphine infusion device designed to deliver continuous treatment throughout the waking day, providing consistent control of OFF time, which is a ...

safety and cost-effectiveness as first-line treatment for hypertension. METHOD: Review of short-term comparative studies, and the outcome of long-term trials with vascular complications of ...

Weakness in facial muscles can cause drooling, further signalling the onset of this serious condition." Understanding these signs and seeking medical attention within the first 2 weeks of symptom ...

Several treatment alternatives have been investigated, such as intraperitoneal chemotherapy, alternative doublets and triplet regimens, in the effort to find an optimal first-line treatment strategy.

Predicting mortality in upper gastrointestinal tract cancer using long short-term memory neural networks. This is an ASCO Meeting Abstract from the 2025 ASCO Gastrointestinal Cancers Symposium. This ...